<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02510820</url>
  </required_header>
  <id_info>
    <org_study_id>EX-MKTG-54</org_study_id>
    <nct_id>NCT02510820</nct_id>
  </id_info>
  <brief_title>The Clinical Performance of the Biofinity Contact Lens (Comfilcon A) With Two Lens Care Systems</brief_title>
  <official_title>The Clinical Performance of the Biofinity Contact Lens (Comfilcon A) With Two Lens Care Systems</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coopervision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coopervision, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This will be a controlled and randomized, single-masked, crossover study in which 48 subjects
      will use the Biofinity Contact Lens (comfilcon A) with each of the two lens care products
      ('solutions'), (Synergi and Biotrue Multi-purpose Solution) for one month each. Follow-up
      visits for each solution will take place at one week, two weeks and four weeks: with a
      one-week 'wash-out' period between the solutions. Key outcome measures for this study include
      biomicroscopic and subjective responses to the lens/solution combinations.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Conjunctival Hyperaemia</measure>
    <time_frame>Baseline, 1 week, 2 weeks, 4 weeks</time_frame>
    <description>Conjunctival hyperaemia of Synergi / comfilcon A combination and Biotrue / comfilcon A combination assessed at baseline, 1 week, 2 week, and 4 week follow-up visits. Grades 0-4, 0=normal, 4=severe.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Limbal Hyperaemia</measure>
    <time_frame>Baseline, 1 week, 2 weeks, 4 weeks</time_frame>
    <description>Limbal hyperaemia of Synergi / comfilcon A combination and Biotrue / comfilcon A combination assessed at baseline, 1 week, 2 week, and 4 week follow-up visits. Grades 0-4, 0=normal, 4=severe.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal Staining</measure>
    <time_frame>Baseline, 1 week, 2 weeks, 4 weeks</time_frame>
    <description>Corneal staining of Synergi / comfilcon A combination and Biotrue / comfilcon A combination assessed at baseline, 1 week, 2 week, and 4 week follow-up visits. Grades 0-4, 0=none, 4=patch.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Papillary Conjunctivitis</measure>
    <time_frame>Baseline, 1 week, 2 weeks, 4 weeks</time_frame>
    <description>Papillary conjunctivitis of Synergi / comfilcon A combination and Biotrue / comfilcon A combination assessed at baseline, 1 week, 2 week, and 4 week follow-up visits. Grades 0-4, 0=normal, 4=severe.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comfort</measure>
    <time_frame>1 week</time_frame>
    <description>Subjective comfort for Synergi / comfilcon A combination and Biotrue / comfilcon A combination is assessed at 1 week visit. Scale 0-100, 0=causes pain, cannot be tolerated, 100=excellent, cannot be felt.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comfort</measure>
    <time_frame>2 weeks</time_frame>
    <description>Subjective comfort for Synergi / comfilcon A combination and Biotrue / comfilcon A combination is assessed at 2 week visit. Scale 0-100, 0=causes pain, cannot be tolerated, 100=excellent, cannot be felt.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comfort</measure>
    <time_frame>4 weeks</time_frame>
    <description>Subjective comfort for Synergi / comfilcon A combination and Biotrue / comfilcon A combination is assessed at 4 week visit. Scale 0-100, 0=causes pain, cannot be tolerated, 100=excellent, cannot be felt.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vision</measure>
    <time_frame>1 week</time_frame>
    <description>Subjective assessment of vision for Synergi / comfilcon A combination and Biotrue / comfilcon A combination was assessed at 1 week visit. Scale 0-100, 0=extremely poor, intolerable levels of variation in vision, 100=excellent, no variation in vision.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vision</measure>
    <time_frame>2 weeks</time_frame>
    <description>Subjective assessment of vision for Synergi / comfilcon A combination and Biotrue / comfilcon A combination was assessed at 2 week visit. Scale 0-100, 0=extremely poor, intolerable levels of variation in vision, 100=excellent, no variation in vision.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vision</measure>
    <time_frame>4 weeks</time_frame>
    <description>Subjective assessment of vision for Synergi / comfilcon A combination and Biotrue / comfilcon A combination was assessed at 4 week visit. Scale 0-100, 0=extremely poor, intolerable levels of variation in vision, 100=excellent, no variation in vision.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Dryness</measure>
    <time_frame>1 week, 2 weeks, 4 weeks</time_frame>
    <description>Subjective assessment of dryness for Synergi / comfilcon A combination and Biotrue / comfilcon A combination was assessed at 1 week, 2 week, and 4 week visit. Scale 0-100, 0=extremely dry 100=not dry at all.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Burning/Stinging</measure>
    <time_frame>1 week, 2 weeks, 4 weeks</time_frame>
    <description>Subjective assessment of burning/stinging for Synergi / comfilcon A combination and Biotrue / comfilcon A combination was assessed at 1 week, 2 week, and 4 week visit. Scale 0-100, 0=Extreme stinging / burning, 100=No stinging / burning sensation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ocular Redness</measure>
    <time_frame>1 week, 2 weeks, 4 weeks</time_frame>
    <description>Subjective ocular redness of Synergi / comfilcon A combination and Biotrue / comfilcon A combination assessed at 1 week, 2 week, and 4 week follow-up visits. Scale 0-100, 0=extremely poor. intolerable levels of redness, 100=excellent, no redness.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ease of Lens Insertion</measure>
    <time_frame>1 week, 2 weeks, 4 weeks</time_frame>
    <description>Subjective assessment of insertionfor Synergi / comfilcon A combination and Biotrue / comfilcon A combination was assessed at 1 week, 2 week, and 4 week follow-up visits. Scale 0-100, 0=unmanageable. lenses impossible to insert, 100=excellent. no problem with lens insertion.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ease of Lens Removal</measure>
    <time_frame>1 week, 2 weeks, 4 weeks</time_frame>
    <description>Subjective assessment of removal for Synergi / comfilcon A combination and Biotrue / comfilcon A combination was assessed at 1 week, 2 week, and 4 week follow-up visits. Scale 0-100, 0=unmanageable. lenses impossible to remove, 100=excellent. no problem with lens remove.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ease of Use of Solution</measure>
    <time_frame>1 week, 2 weeks, 4 weeks</time_frame>
    <description>Subjective ease of use for Synergi / comfilcon A combination and Biotrue / comfilcon A combination assessed at 1 week, 2 week, and 4 week follow-up visit. Scale 0-100, 0=very difficult, 100=very easy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall Score</measure>
    <time_frame>1 week, 2 weeks, 4 weeks</time_frame>
    <description>Subjective overall scores Synergi / comfilcon A combination and Biotrue / comfilcon A combination assessed at 1 week, 2 week, and 4 week follow-up visit. Scale 0-100, 0=extremely poor, 100=excellent, highly impressed.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>Synergi / comfilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants were randomized to wear the Synergi / comfilcon A combination for one month during the cross over study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Biotrue / comfilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants were randomized to wear the Biotrue / comfilcon A combination for one month during the cross over study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>comfilcon A</intervention_name>
    <description>soft contact lens</description>
    <arm_group_label>Synergi / comfilcon A</arm_group_label>
    <arm_group_label>Biotrue / comfilcon A</arm_group_label>
    <other_name>Biofinity</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Synergi</intervention_name>
    <description>Multipurpose solution</description>
    <arm_group_label>Synergi / comfilcon A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Biotrue</intervention_name>
    <description>Multipurpose solution</description>
    <arm_group_label>Biotrue / comfilcon A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>stenfilcon A</intervention_name>
    <description>daily disposable contact lenses for washout period</description>
    <arm_group_label>Synergi / comfilcon A</arm_group_label>
    <arm_group_label>Biotrue / comfilcon A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. They are of legal age and capacity to volunteer.

          2. They understand their rights as a research subject and are willing and able to sign a
             Statement of Informed Consent.

          3. They are willing and able to follow the protocol.

          4. They agree not to participate in other clinical research for the duration of this
             study.

          5. They have a contact lens spherical prescription between - 0.50 to - 6.00 (inclusive)

          6. They have a spectacle cylindrical correction of -1.00D (Diopters) or less in each eye.

          7. At dispensing, they can attain at least 0.10 logMAR distance high contrast visual
             acuity in each eye with the study lenses within the available power range.

          8. They currently use silicone hydrogel soft contact lenses.

          9. They are willing to comply with the wear schedule (at least 5 days per week, â‰¥8
             hours/day).

        Exclusion Criteria:

          1. They have an ocular disorder which would normally contra-indicate contact lens wear.

          2. They have a systemic disorder which would normally contra-indicate contact lens wear.

          3. They are using any topical medication such as eye drops or ointment.

          4. They have had cataract surgery.

          5. They have had corneal refractive surgery.

          6. They have any corneal distortion resulting from previous hard or rigid lens wear or
             have keratoconus.

          7. They are pregnant or lactating.

          8. They have any ocular abnormality which would, in the opinion of the investigator,
             normally contraindicate contact lens wear.

          9. They have any infectious disease which would, in the opinion of the investigator,
             contraindicate contact lens wear or pose a risk to study personnel; or they have any
             immunosuppressive disease (e.g. HIV), or a history of anaphylaxis or severe allergic
             reaction.

         10. They have taken part in any other contact lens or care solution clinical trial or
             research, within two weeks prior to starting this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carole Maldonado-Codina</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Manchester</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Eurolens Research</name>
      <address>
        <city>Manchester</city>
        <zip>M13 9PL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 16, 2015</study_first_submitted>
  <study_first_submitted_qc>July 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 29, 2015</study_first_posted>
  <results_first_submitted>January 30, 2017</results_first_submitted>
  <results_first_submitted_qc>January 30, 2017</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 1, 2017</results_first_posted>
  <last_update_submitted>January 30, 2017</last_update_submitted>
  <last_update_submitted_qc>January 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Three subjects were not dispensed the combination of multipurpose solutions.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Synergi/Comfilcon A Combo, Then Biotrue/Comfilcon A Combo</title>
          <description>Participants were randomized to wear Synergi/comfilcon A combination for one month, then cross over to the alternative Biotrue/comfilcon A combination.</description>
        </group>
        <group group_id="P2">
          <title>Biotrue/Comfilcon A Combo, Then Synergi/Comfilcon A Combo</title>
          <description>Participants were randomized to wear Biotrue/comfilcon A combination for one month, then cross over to the alternative Synergi/comfilcon A combination.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Intervention (4 Weeks)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Washout (1 Week)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Second Intervention (4 Weeks)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Overall Baseline Characteristics</title>
          <description>Participants were randomized to wear either the Synergi/comfilcon A or Biotrue/comfilcon A combination for one month, then cross over to the alternative combination.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="51"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.3" spread="10.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Conjunctival Hyperaemia</title>
        <description>Conjunctival hyperaemia of Synergi / comfilcon A combination and Biotrue / comfilcon A combination assessed at baseline, 1 week, 2 week, and 4 week follow-up visits. Grades 0-4, 0=normal, 4=severe.</description>
        <time_frame>Baseline, 1 week, 2 weeks, 4 weeks</time_frame>
        <population>The differences in the sample size of the results vary due to lack of subjects attending their follow-up visits, however they completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Synergi / Comfilcon A</title>
            <description>Participants were randomized to wear the Synergi / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Synergi: Multipurpose solution</description>
          </group>
          <group group_id="O2">
            <title>Biotrue / Comfilcon A</title>
            <description>Participants were randomized to wear the Biotrue / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Biotrue: Multipurpose solution</description>
          </group>
        </group_list>
        <measure>
          <title>Conjunctival Hyperaemia</title>
          <description>Conjunctival hyperaemia of Synergi / comfilcon A combination and Biotrue / comfilcon A combination assessed at baseline, 1 week, 2 week, and 4 week follow-up visits. Grades 0-4, 0=normal, 4=severe.</description>
          <population>The differences in the sample size of the results vary due to lack of subjects attending their follow-up visits, however they completed the study.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="47"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="48"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.84" spread="0.24"/>
                    <measurement group_id="O2" value="0.87" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 week</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="47"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.87" spread="0.21"/>
                    <measurement group_id="O2" value="0.87" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.88" spread="0.24"/>
                    <measurement group_id="O2" value="0.83" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.90" spread="0.21"/>
                    <measurement group_id="O2" value="0.82" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Limbal Hyperaemia</title>
        <description>Limbal hyperaemia of Synergi / comfilcon A combination and Biotrue / comfilcon A combination assessed at baseline, 1 week, 2 week, and 4 week follow-up visits. Grades 0-4, 0=normal, 4=severe.</description>
        <time_frame>Baseline, 1 week, 2 weeks, 4 weeks</time_frame>
        <population>The differences in the sample size of the results vary due to lack of subjects attending their follow-up visits, however they completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Synergi / Comfilcon A</title>
            <description>Participants were randomized to wear the Synergi / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens Synergi: Multipurpose solution</description>
          </group>
          <group group_id="O2">
            <title>Biotrue / Comfilcon A</title>
            <description>Participants were randomized to wear the Biotrue / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Biotrue: Multipurpose solution</description>
          </group>
        </group_list>
        <measure>
          <title>Limbal Hyperaemia</title>
          <description>Limbal hyperaemia of Synergi / comfilcon A combination and Biotrue / comfilcon A combination assessed at baseline, 1 week, 2 week, and 4 week follow-up visits. Grades 0-4, 0=normal, 4=severe.</description>
          <population>The differences in the sample size of the results vary due to lack of subjects attending their follow-up visits, however they completed the study.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="47"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="48"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.73" spread="0.26"/>
                    <measurement group_id="O2" value="0.77" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 week</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="47"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.80" spread="0.23"/>
                    <measurement group_id="O2" value="0.75" spread="0.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.73" spread="0.25"/>
                    <measurement group_id="O2" value="0.70" spread="0.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.78" spread="0.22"/>
                    <measurement group_id="O2" value="0.72" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Corneal Staining</title>
        <description>Corneal staining of Synergi / comfilcon A combination and Biotrue / comfilcon A combination assessed at baseline, 1 week, 2 week, and 4 week follow-up visits. Grades 0-4, 0=none, 4=patch.</description>
        <time_frame>Baseline, 1 week, 2 weeks, 4 weeks</time_frame>
        <population>The differences in the sample size of the results vary due to lack of subjects attending their follow-up visits, however they completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Synergi / Comfilcon A</title>
            <description>Participants were randomized to wear the Synergi / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Synergi: Multipurpose solution</description>
          </group>
          <group group_id="O2">
            <title>Biotrue / Comfilcon A</title>
            <description>Participants were randomized to wear the Biotrue / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Biotrue: Multipurpose solution</description>
          </group>
        </group_list>
        <measure>
          <title>Corneal Staining</title>
          <description>Corneal staining of Synergi / comfilcon A combination and Biotrue / comfilcon A combination assessed at baseline, 1 week, 2 week, and 4 week follow-up visits. Grades 0-4, 0=none, 4=patch.</description>
          <population>The differences in the sample size of the results vary due to lack of subjects attending their follow-up visits, however they completed the study.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="47"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="48"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.30" spread="0.48"/>
                    <measurement group_id="O2" value="0.17" spread="0.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 week</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="47"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.34" spread="0.40"/>
                    <measurement group_id="O2" value="0.67" spread="0.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.38" spread="0.46"/>
                    <measurement group_id="O2" value="0.59" spread="0.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.31" spread="0.42"/>
                    <measurement group_id="O2" value="0.62" spread="0.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Papillary Conjunctivitis</title>
        <description>Papillary conjunctivitis of Synergi / comfilcon A combination and Biotrue / comfilcon A combination assessed at baseline, 1 week, 2 week, and 4 week follow-up visits. Grades 0-4, 0=normal, 4=severe.</description>
        <time_frame>Baseline, 1 week, 2 weeks, 4 weeks</time_frame>
        <population>The differences in the sample size of the results vary due to lack of subjects attending their follow-up visits, however they completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Synergi / Comfilcon A</title>
            <description>Participants were randomized to wear the Synergi / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Synergi: Multipurpose solution</description>
          </group>
          <group group_id="O2">
            <title>Biotrue / Comfilcon A</title>
            <description>Participants were randomized to wear the Biotrue / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Biotrue: Multipurpose solution</description>
          </group>
        </group_list>
        <measure>
          <title>Papillary Conjunctivitis</title>
          <description>Papillary conjunctivitis of Synergi / comfilcon A combination and Biotrue / comfilcon A combination assessed at baseline, 1 week, 2 week, and 4 week follow-up visits. Grades 0-4, 0=normal, 4=severe.</description>
          <population>The differences in the sample size of the results vary due to lack of subjects attending their follow-up visits, however they completed the study.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="47"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="48"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.04" spread="0.22"/>
                    <measurement group_id="O2" value="1.07" spread="0.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 week</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="47"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.05" spread="0.24"/>
                    <measurement group_id="O2" value="1.04" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.05" spread="0.26"/>
                    <measurement group_id="O2" value="1.06" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.09" spread="0.24"/>
                    <measurement group_id="O2" value="1.06" spread="0.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Comfort</title>
        <description>Subjective comfort for Synergi / comfilcon A combination and Biotrue / comfilcon A combination is assessed at 1 week visit. Scale 0-100, 0=causes pain, cannot be tolerated, 100=excellent, cannot be felt.</description>
        <time_frame>1 week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Synergi / Comfilcon A</title>
            <description>Participants were randomized to wear the Synergi / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Synergi: Multipurpose solution</description>
          </group>
          <group group_id="O2">
            <title>Biotrue / Comfilcon A</title>
            <description>Participants were randomized to wear the Biotrue / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Biotrue: Multipurpose solution</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort</title>
          <description>Subjective comfort for Synergi / comfilcon A combination and Biotrue / comfilcon A combination is assessed at 1 week visit. Scale 0-100, 0=causes pain, cannot be tolerated, 100=excellent, cannot be felt.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Comfort after insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.7" spread="11.4"/>
                    <measurement group_id="O2" value="83.4" spread="17.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Comfort before removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.8" spread="17.2"/>
                    <measurement group_id="O2" value="72.4" spread="22.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall comfort</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.6" spread="11.8"/>
                    <measurement group_id="O2" value="82.8" spread="13.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Comfort</title>
        <description>Subjective comfort for Synergi / comfilcon A combination and Biotrue / comfilcon A combination is assessed at 2 week visit. Scale 0-100, 0=causes pain, cannot be tolerated, 100=excellent, cannot be felt.</description>
        <time_frame>2 weeks</time_frame>
        <population>The difference in the sample size of the results vary due to lack of subjects attending their follow-up visits, however they completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Synergi / Comfilcon A</title>
            <description>Participants were randomized to wear the Synergi / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Synergi: Multipurpose solution</description>
          </group>
          <group group_id="O2">
            <title>Biotrue / Comfilcon A</title>
            <description>Participants were randomized to wear the Biotrue / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Biotrue: Multipurpose solution</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort</title>
          <description>Subjective comfort for Synergi / comfilcon A combination and Biotrue / comfilcon A combination is assessed at 2 week visit. Scale 0-100, 0=causes pain, cannot be tolerated, 100=excellent, cannot be felt.</description>
          <population>The difference in the sample size of the results vary due to lack of subjects attending their follow-up visits, however they completed the study.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Comfort after insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.0" spread="12.6"/>
                    <measurement group_id="O2" value="85.6" spread="14.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Comfort before removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.1" spread="19.4"/>
                    <measurement group_id="O2" value="73.9" spread="20.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall comfort</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.7" spread="14.9"/>
                    <measurement group_id="O2" value="83.2" spread="14.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Comfort</title>
        <description>Subjective comfort for Synergi / comfilcon A combination and Biotrue / comfilcon A combination is assessed at 4 week visit. Scale 0-100, 0=causes pain, cannot be tolerated, 100=excellent, cannot be felt.</description>
        <time_frame>4 weeks</time_frame>
        <population>The differences in the sample size of the results vary due to lack of subjects attending their follow-up visits, however they completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Synergi / Comfilcon A</title>
            <description>Participants were randomized to wear the Synergi / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Synergi: Multipurpose solution</description>
          </group>
          <group group_id="O2">
            <title>Biotrue / Comfilcon A</title>
            <description>Participants were randomized to wear the Biotrue / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Biotrue: Multipurpose solution</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort</title>
          <description>Subjective comfort for Synergi / comfilcon A combination and Biotrue / comfilcon A combination is assessed at 4 week visit. Scale 0-100, 0=causes pain, cannot be tolerated, 100=excellent, cannot be felt.</description>
          <population>The differences in the sample size of the results vary due to lack of subjects attending their follow-up visits, however they completed the study.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Comfort after insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.3" spread="11.0"/>
                    <measurement group_id="O2" value="87.3" spread="15.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Comfort before removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.1" spread="21.2"/>
                    <measurement group_id="O2" value="75.0" spread="20.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall comfort</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.3" spread="14.3"/>
                    <measurement group_id="O2" value="84.5" spread="14.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Vision</title>
        <description>Subjective assessment of vision for Synergi / comfilcon A combination and Biotrue / comfilcon A combination was assessed at 1 week visit. Scale 0-100, 0=extremely poor, intolerable levels of variation in vision, 100=excellent, no variation in vision.</description>
        <time_frame>1 week</time_frame>
        <population>The differences in the sample size of the results vary due to lack of subjects attending their follow-up visits, however they completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Synergi / Comfilcon A</title>
            <description>Participants were randomized to wear the Synergi / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Synergi: Multipurpose solution</description>
          </group>
          <group group_id="O2">
            <title>Biotrue / Comfilcon A</title>
            <description>Participants were randomized to wear the Biotrue / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Biotrue: Multipurpose solution</description>
          </group>
        </group_list>
        <measure>
          <title>Vision</title>
          <description>Subjective assessment of vision for Synergi / comfilcon A combination and Biotrue / comfilcon A combination was assessed at 1 week visit. Scale 0-100, 0=extremely poor, intolerable levels of variation in vision, 100=excellent, no variation in vision.</description>
          <population>The differences in the sample size of the results vary due to lack of subjects attending their follow-up visits, however they completed the study.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Distance vision</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="47"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.1" spread="12.7"/>
                    <measurement group_id="O2" value="92.1" spread="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Variable vision</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="47"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.1" spread="12.7"/>
                    <measurement group_id="O2" value="92.1" spread="12.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Night vision</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.4" spread="12.3"/>
                    <measurement group_id="O2" value="91.6" spread="11.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Vision</title>
        <description>Subjective assessment of vision for Synergi / comfilcon A combination and Biotrue / comfilcon A combination was assessed at 2 week visit. Scale 0-100, 0=extremely poor, intolerable levels of variation in vision, 100=excellent, no variation in vision.</description>
        <time_frame>2 weeks</time_frame>
        <population>The differences in the sample size of the results vary due to lack of subjects attending their follow-up visits, however they completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Synergi / Comfilcon A</title>
            <description>Participants were randomized to wear the Synergi / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Synergi: Multipurpose solution</description>
          </group>
          <group group_id="O2">
            <title>Biotrue / Comfilcon A</title>
            <description>Participants were randomized to wear the Biotrue / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Biotrue: Multipurpose solution</description>
          </group>
        </group_list>
        <measure>
          <title>Vision</title>
          <description>Subjective assessment of vision for Synergi / comfilcon A combination and Biotrue / comfilcon A combination was assessed at 2 week visit. Scale 0-100, 0=extremely poor, intolerable levels of variation in vision, 100=excellent, no variation in vision.</description>
          <population>The differences in the sample size of the results vary due to lack of subjects attending their follow-up visits, however they completed the study.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Distance vision</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.8" spread="8.7"/>
                    <measurement group_id="O2" value="91.1" spread="13.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Variable vision</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.3" spread="9.6"/>
                    <measurement group_id="O2" value="90.5" spread="12.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Night vision</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.2" spread="8.1"/>
                    <measurement group_id="O2" value="90.8" spread="12.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Vision</title>
        <description>Subjective assessment of vision for Synergi / comfilcon A combination and Biotrue / comfilcon A combination was assessed at 4 week visit. Scale 0-100, 0=extremely poor, intolerable levels of variation in vision, 100=excellent, no variation in vision.</description>
        <time_frame>4 weeks</time_frame>
        <population>The differences in the sample size of the results vary due to lack of subjects attending their follow-up visits, however they completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Synergi / Comfilcon A</title>
            <description>Participants were randomized to wear the Synergi / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Synergi: Multipurpose solution</description>
          </group>
          <group group_id="O2">
            <title>Biotrue / Comfilcon A</title>
            <description>Participants were randomized to wear the Biotrue / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Biotrue: Multipurpose solution</description>
          </group>
        </group_list>
        <measure>
          <title>Vision</title>
          <description>Subjective assessment of vision for Synergi / comfilcon A combination and Biotrue / comfilcon A combination was assessed at 4 week visit. Scale 0-100, 0=extremely poor, intolerable levels of variation in vision, 100=excellent, no variation in vision.</description>
          <population>The differences in the sample size of the results vary due to lack of subjects attending their follow-up visits, however they completed the study.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Distance vision</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.5" spread="8.8"/>
                    <measurement group_id="O2" value="92.6" spread="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Variable vision</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.6" spread="12.5"/>
                    <measurement group_id="O2" value="94.1" spread="9.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Night vision</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.1" spread="8.6"/>
                    <measurement group_id="O2" value="91.9" spread="11.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Dryness</title>
        <description>Subjective assessment of dryness for Synergi / comfilcon A combination and Biotrue / comfilcon A combination was assessed at 1 week, 2 week, and 4 week visit. Scale 0-100, 0=extremely dry 100=not dry at all.</description>
        <time_frame>1 week, 2 weeks, 4 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Synergi / Comfilcon A</title>
            <description>Participants were randomized to wear the Synergi / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Synergi: Multipurpose solution</description>
          </group>
          <group group_id="O2">
            <title>Biotrue / Comfilcon A</title>
            <description>Participants were randomized to wear the Biotrue / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Biotrue: Multipurpose solution</description>
          </group>
        </group_list>
        <measure>
          <title>Dryness</title>
          <description>Subjective assessment of dryness for Synergi / comfilcon A combination and Biotrue / comfilcon A combination was assessed at 1 week, 2 week, and 4 week visit. Scale 0-100, 0=extremely dry 100=not dry at all.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="47"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 week</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82.8" spread="16.3"/>
                    <measurement group_id="O2" value="79.3" spread="20.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.5" spread="20.5"/>
                    <measurement group_id="O2" value="80.2" spread="19.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.9" spread="20.9"/>
                    <measurement group_id="O2" value="81.7" spread="20.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Burning/Stinging</title>
        <description>Subjective assessment of burning/stinging for Synergi / comfilcon A combination and Biotrue / comfilcon A combination was assessed at 1 week, 2 week, and 4 week visit. Scale 0-100, 0=Extreme stinging / burning, 100=No stinging / burning sensation.</description>
        <time_frame>1 week, 2 weeks, 4 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Synergi / Comfilcon A</title>
            <description>Participants were randomized to wear the Synergi / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Synergi: Multipurpose solution</description>
          </group>
          <group group_id="O2">
            <title>Biotrue / Comfilcon A</title>
            <description>Participants were randomized to wear the Biotrue / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Biotrue: Multipurpose solution</description>
          </group>
        </group_list>
        <measure>
          <title>Burning/Stinging</title>
          <description>Subjective assessment of burning/stinging for Synergi / comfilcon A combination and Biotrue / comfilcon A combination was assessed at 1 week, 2 week, and 4 week visit. Scale 0-100, 0=Extreme stinging / burning, 100=No stinging / burning sensation.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="47"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 week</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.3" spread="13.0"/>
                    <measurement group_id="O2" value="95.7" spread="9.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.0" spread="8.4"/>
                    <measurement group_id="O2" value="96.8" spread="8.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.6" spread="10.9"/>
                    <measurement group_id="O2" value="96.5" spread="9.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Ocular Redness</title>
        <description>Subjective ocular redness of Synergi / comfilcon A combination and Biotrue / comfilcon A combination assessed at 1 week, 2 week, and 4 week follow-up visits. Scale 0-100, 0=extremely poor. intolerable levels of redness, 100=excellent, no redness.</description>
        <time_frame>1 week, 2 weeks, 4 weeks</time_frame>
        <population>The differences in the sample size of the results vary due to lack of subjects attending their follow-up visits, however they completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Synergi / Comfilcon A</title>
            <description>Participants were randomized to wear the Synergi / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Synergi: Multipurpose solution</description>
          </group>
          <group group_id="O2">
            <title>Biotrue / Comfilcon A</title>
            <description>Participants were randomized to wear the Biotrue / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Biotrue: Multipurpose solution</description>
          </group>
        </group_list>
        <measure>
          <title>Ocular Redness</title>
          <description>Subjective ocular redness of Synergi / comfilcon A combination and Biotrue / comfilcon A combination assessed at 1 week, 2 week, and 4 week follow-up visits. Scale 0-100, 0=extremely poor. intolerable levels of redness, 100=excellent, no redness.</description>
          <population>The differences in the sample size of the results vary due to lack of subjects attending their follow-up visits, however they completed the study.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 week</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="47"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.0" spread="9.9"/>
                    <measurement group_id="O2" value="96.8" spread="6.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.4" spread="9.6"/>
                    <measurement group_id="O2" value="96.5" spread="8.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.5" spread="8.1"/>
                    <measurement group_id="O2" value="95.7" spread="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Ease of Lens Insertion</title>
        <description>Subjective assessment of insertionfor Synergi / comfilcon A combination and Biotrue / comfilcon A combination was assessed at 1 week, 2 week, and 4 week follow-up visits. Scale 0-100, 0=unmanageable. lenses impossible to insert, 100=excellent. no problem with lens insertion.</description>
        <time_frame>1 week, 2 weeks, 4 weeks</time_frame>
        <population>The differences in the sample size of the results vary due to lack of subjects attending their follow-up visits, however they completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Synergi / Comfilcon A</title>
            <description>Participants were randomized to wear the Synergi / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Synergi: Multipurpose solution</description>
          </group>
          <group group_id="O2">
            <title>Biotrue / Comfilcon A</title>
            <description>Participants were randomized to wear the Biotrue / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Biotrue: Multipurpose solution</description>
          </group>
        </group_list>
        <measure>
          <title>Ease of Lens Insertion</title>
          <description>Subjective assessment of insertionfor Synergi / comfilcon A combination and Biotrue / comfilcon A combination was assessed at 1 week, 2 week, and 4 week follow-up visits. Scale 0-100, 0=unmanageable. lenses impossible to insert, 100=excellent. no problem with lens insertion.</description>
          <population>The differences in the sample size of the results vary due to lack of subjects attending their follow-up visits, however they completed the study.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 week</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="47"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.9" spread="11.8"/>
                    <measurement group_id="O2" value="93.2" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.8" spread="8.8"/>
                    <measurement group_id="O2" value="93.4" spread="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.8" spread="8.7"/>
                    <measurement group_id="O2" value="93.5" spread="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Ease of Lens Removal</title>
        <description>Subjective assessment of removal for Synergi / comfilcon A combination and Biotrue / comfilcon A combination was assessed at 1 week, 2 week, and 4 week follow-up visits. Scale 0-100, 0=unmanageable. lenses impossible to remove, 100=excellent. no problem with lens remove.</description>
        <time_frame>1 week, 2 weeks, 4 weeks</time_frame>
        <population>The differences in the sample size of the results vary due to lack of subjects attending their follow-up visits, however they completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Synergi / Comfilcon A</title>
            <description>Participants were randomized to wear the Synergi / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Synergi: Multipurpose solution</description>
          </group>
          <group group_id="O2">
            <title>Biotrue / Comfilcon A</title>
            <description>Participants were randomized to wear the Biotrue / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Biotrue: Multipurpose solution</description>
          </group>
        </group_list>
        <measure>
          <title>Ease of Lens Removal</title>
          <description>Subjective assessment of removal for Synergi / comfilcon A combination and Biotrue / comfilcon A combination was assessed at 1 week, 2 week, and 4 week follow-up visits. Scale 0-100, 0=unmanageable. lenses impossible to remove, 100=excellent. no problem with lens remove.</description>
          <population>The differences in the sample size of the results vary due to lack of subjects attending their follow-up visits, however they completed the study.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 week</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="47"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.1" spread="14.0"/>
                    <measurement group_id="O2" value="92.2" spread="11.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.7" spread="11.9"/>
                    <measurement group_id="O2" value="94.0" spread="10.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.3" spread="11.2"/>
                    <measurement group_id="O2" value="94.4" spread="8.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Ease of Use of Solution</title>
        <description>Subjective ease of use for Synergi / comfilcon A combination and Biotrue / comfilcon A combination assessed at 1 week, 2 week, and 4 week follow-up visit. Scale 0-100, 0=very difficult, 100=very easy</description>
        <time_frame>1 week, 2 weeks, 4 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Synergi / Comfilcon A</title>
            <description>Participants were randomized to wear the Synergi / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Synergi: Multipurpose solution</description>
          </group>
          <group group_id="O2">
            <title>Biotrue / Comfilcon A</title>
            <description>Participants were randomized to wear the Biotrue / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Biotrue: Multipurpose solution</description>
          </group>
        </group_list>
        <measure>
          <title>Ease of Use of Solution</title>
          <description>Subjective ease of use for Synergi / comfilcon A combination and Biotrue / comfilcon A combination assessed at 1 week, 2 week, and 4 week follow-up visit. Scale 0-100, 0=very difficult, 100=very easy</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="47"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 week</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.7" spread="17.3"/>
                    <measurement group_id="O2" value="92.2" spread="11.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.2" spread="17.5"/>
                    <measurement group_id="O2" value="93.6" spread="11.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.7" spread="15.3"/>
                    <measurement group_id="O2" value="92.7" spread="12.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Overall Score</title>
        <description>Subjective overall scores Synergi / comfilcon A combination and Biotrue / comfilcon A combination assessed at 1 week, 2 week, and 4 week follow-up visit. Scale 0-100, 0=extremely poor, 100=excellent, highly impressed.</description>
        <time_frame>1 week, 2 weeks, 4 weeks</time_frame>
        <population>Data not collected as follows: 2 weeks (1 participant) and 4 weeks (1 participant - Synergi, 1 participant - Biotrue).</population>
        <group_list>
          <group group_id="O1">
            <title>Synergi / Comfilcon A</title>
            <description>Participants were randomized to wear the Synergi / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Synergi: Multipurpose solution</description>
          </group>
          <group group_id="O2">
            <title>Biotrue / Comfilcon A</title>
            <description>Participants were randomized to wear the Biotrue / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Biotrue: Multipurpose solution</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Score</title>
          <description>Subjective overall scores Synergi / comfilcon A combination and Biotrue / comfilcon A combination assessed at 1 week, 2 week, and 4 week follow-up visit. Scale 0-100, 0=extremely poor, 100=excellent, highly impressed.</description>
          <population>Data not collected as follows: 2 weeks (1 participant) and 4 weeks (1 participant - Synergi, 1 participant - Biotrue).</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 week</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="47"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.3" spread="12.6"/>
                    <measurement group_id="O2" value="90.6" spread="11.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.3" spread="15.0"/>
                    <measurement group_id="O2" value="90.7" spread="12.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.8" spread="15.4"/>
                    <measurement group_id="O2" value="91.7" spread="12.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Synergi/Comfilcon A Combo, Then Biotrue/Comfilcon A Combo</title>
          <description>Participants were randomized to wear the Synergi / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Synergi: Multipurpose solution
Biotrue: Multipurpose solution</description>
        </group>
        <group group_id="E2">
          <title>Biotrue/Comfilcon A Combo, Then Synergi/Comfilcon A Combo</title>
          <description>Participants were randomized to wear the Biotrue / comfilcon A combination for one month during the cross over study.
comfilcon A: soft contact lens
Biotrue: Multipurpose solution
Synergi: Multipurpose solution</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Sr. Manager Global Medical Scientific Affairs</name_or_title>
      <organization>CooperVision</organization>
      <phone>(925) 621-3761</phone>
      <email>javega@coopervision.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

